[BRNS] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[BRNS] Barinthus Biotherapeutics plc
Announcement Date
30-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 14.20%
YoY- -800.31%
Quarter Report
BRNS's Result
BRNS's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 5,369 0 334 468 6,457 6,165 17,063 -53.64%
PBT -18,268 -14,713 -24,960 -18,739 -23,182 7,547 14,774 -
Tax -827 -603 -1,136 -516 -2,019 -674 -915 -6.50%
NP -17,443 -14,072 -23,802 -18,180 -21,189 8,242 15,693 -
Tax Rate - - - - - 8.93% 6.19% -
Total Cost 22,813 14,072 24,136 18,648 27,646 -2,077 1,370 548.75%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -324.88 0.00 -7,126.35 -3,884.62 -328.16 133.69 91.97 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.45 -0.37 -0.62 -0.48 -0.56 0.22 0.42 -
EPS Diluted -0.45 -0.37 -0.62 -0.48 -0.56 0.22 0.41 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.